To see the other types of publications on this topic, follow the link: Skin pharmacology.

Journal articles on the topic 'Skin pharmacology'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Skin pharmacology.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Guy, Richard H. "Skin Pharmacokinetics. Pharmacology and Skin, Volume 1." Journal of Pharmaceutical Sciences 77, no. 6 (1988): 557. http://dx.doi.org/10.1002/jps.2600770621.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ayres, Peter J. "Pharmacology and the skin. Vol. 1. Skin pharmacokinetics." Journal of the American Academy of Dermatology 18, no. 6 (1988): 1372–74. http://dx.doi.org/10.1016/s0190-9622(88)80134-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Bouclier, M., D. Cavey, N. Kail, and C. Hensby. "Experimental models in skin pharmacology." Pharmacological Reviews 42, no. 2 (1990): 127–54. https://doi.org/10.1016/s0031-6997(25)00042-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Greenbaum, Lowell M. "Clinical pharmacology of skin disease." Journal of the American Academy of Dermatology 12, no. 1 (1985): 149. http://dx.doi.org/10.1016/s0190-9622(85)80268-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Stingl, G. "Immune pharmacology of skin diseases." Journal of the European Academy of Dermatology and Venereology 5, no. 1 (1995): S181. http://dx.doi.org/10.1016/0926-9959(95)96518-d.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Bouclier, Martine. "Pharmacology of the skin I." Trends in Pharmacological Sciences 10, no. 8 (1989): 338. http://dx.doi.org/10.1016/0165-6147(89)90071-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Fine, Jo-David. "Clinical Pharmacology of Skin Disease." Archives of Dermatology 121, no. 6 (1985): 809. http://dx.doi.org/10.1001/archderm.1985.01660060123039.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

STINGL, G. "Introduction: Immune pharmacology of skin diseases." British Journal of Dermatology 135 (September 1996): 1. http://dx.doi.org/10.1111/j.1365-2133.1996.tb00700.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Cracowski, Jean-Luc, and Matthieu Roustit. "Pharmacology of the human skin microcirculation." Microvascular Research 80, no. 1 (2010): 1. http://dx.doi.org/10.1016/j.mvr.2010.03.005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Goldner, Ronald. "Skin Pharmacology and Toxicology: Recent Advances." Archives of Dermatology 128, no. 4 (1992): 577. http://dx.doi.org/10.1001/archderm.1992.01680140161030.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Chambers, Henry F. "Pharmacology and the Treatment of Complicated Skin and Skin-Structure Infections." New England Journal of Medicine 370, no. 23 (2014): 2238–39. http://dx.doi.org/10.1056/nejme1405078.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

West, Dennis P. "Book Review: Clinical Pharmacology of Skin Disease." Drug Intelligence & Clinical Pharmacy 19, no. 4 (1985): 323. http://dx.doi.org/10.1177/106002808501900434.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Lademann, Jürgen. "To the Readers and Authors of Skin Pharmacology and Applied Skin Physiology." Skin Pharmacology and Physiology 16, no. 1 (2003): 3. http://dx.doi.org/10.1159/000068293.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Simons, F. Estelle R., Norman A. Silver, Xiaochen Gu, and Keith J. Simons. "Clinical pharmacology of H1-antihistamines in the skin." Journal of Allergy and Clinical Immunology 110, no. 5 (2002): 777–83. http://dx.doi.org/10.1067/mai.2002.129123.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

N. Rabb, Dr Umakant. "Pharmacology of Karaviradi Varga According to Dhanwantari Nighantu." Galore International Journal of Health Sciences and Research 7, no. 2 (2022): 21–28. http://dx.doi.org/10.52403/gijhsr.20220404.

Full text
Abstract:
The Karaviradi Varga is a group of drugs used in various diseases. The Karavira, Dhattura, Langali, Bhringaraj, Arkapushpa, Kakamachi, Moolak, Shigru, Sarshapa, Bhustrina,Tulasi, Jambira, Kutheraa, Sumukha, Asuri drugs are taken and mixed with Takra(Butter milk) and Sauvira(Fermented barley water) liquid and applied on skin relieve Sidhma, Pama, Pitaka, Krimi, Kustha etc skin diseases. The oil is prepared by these drugs and applied on skin helps to relieve skin diseases. The Kandira Jalapippali, Rasona, Grinjana, Palandu, Durduma are used in the Kriminashana(Worms infestation). The Kadali, Sin
APA, Harvard, Vancouver, ISO, and other styles
16

Schur, Nina, Natasha Doshi, Lexi Garber, Marcia Ballantyne, and Milaan Shah. "Expanding Therapeutic Applications of Tofacitinib in Immune-Mediated Skin Disorders: A Comprehensive Review." SKIN The Journal of Cutaneous Medicine 9, no. 2 (2025): 2175–83. https://doi.org/10.25251/skin.9.2.3.

Full text
Abstract:
Tofacitinib, a Janus kinase (JAK) inhibitor targeting JAK1 and JAK3, has gained attention for its immunomodulatory effects, particularly in autoimmune and inflammatory conditions. While initially approved for rheumatoid arthritis, its off-label uses in dermatology are expanding, with promising results in conditions such as vitiligo, alopecia areata, atopic dermatitis, psoriasis, and plaque psoriasis. By inhibiting the JAK-STAT signaling pathway, tofacitinib reduces cytokine-mediated inflammation and immune cell activation, offering a novel therapeutic option for dermatological disorders where
APA, Harvard, Vancouver, ISO, and other styles
17

Walsh, SA. "Dermatological discovery: the frontiers between genetics, pharmacology and the patient." Journal of the Royal College of Physicians of Edinburgh 39, no. 4 (2009): 1–4. https://doi.org/10.1177/1478271520093904028.

Full text
Abstract:
Advances in the fields of genetics and pharmacology and the understanding of disease mechanisms have occurred apace in recent years in dermatology. As the pathophysiology of skin diseases become clearer, treatments have become more focused and effective, but new treatments bring new sideeffect profiles and further considerations for the prescribing physician. The diagnostics of skin disease have also progressed and the role of automated systems in the recognition of skin lesions is being explored. Integration of new knowledge and old is a challenge to the modern physician treating patients wit
APA, Harvard, Vancouver, ISO, and other styles
18

Guo, Haoran, Hongliang Zeng, Chuhan Fu, et al. "Identification of Sitogluside as a Potential Skin-Pigmentation-Reducing Agent through Network Pharmacology." Oxidative Medicine and Cellular Longevity 2021 (September 23, 2021): 1–16. http://dx.doi.org/10.1155/2021/4883398.

Full text
Abstract:
Many traditional Chinese medicines (TCMs) with skin-whitening properties have been recorded in the Ben-Cao-Gang-Mu and in folk prescriptions, and some literature confirms that their extracts do have the potential to inhibit pigmentation. However, no systematic studies have identified the specific regulatory mechanisms of the potential active ingredients. The aim of this study was to screen the ingredients in TCMs that inhibit skin pigmentation through a network pharmacology system and to explore underlying mechanisms. We identified 148 potential active ingredients from 14 TCMs, and based on th
APA, Harvard, Vancouver, ISO, and other styles
19

Mendoza, Natalia, and Stephen K. Tyring. "Emerging drugs for complicated skin and skin-structure infections." Expert Opinion on Emerging Drugs 15, no. 3 (2010): 509–20. http://dx.doi.org/10.1517/14728214.2010.497486.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Sanabria-de la Torre, Raquel, Ana Fernández-González, María I. Quiñones-Vico, Trinidad Montero-Vilchez, and Salvador Arias-Santiago. "Bioengineered Skin Intended as In Vitro Model for Pharmacosmetics, Skin Disease Study and Environmental Skin Impact Analysis." Biomedicines 8, no. 11 (2020): 464. http://dx.doi.org/10.3390/biomedicines8110464.

Full text
Abstract:
This review aims to be an update of Bioengineered Artificial Skin Substitutes (BASS) applications. At the first moment, they were created as an attempt to replace native skin grafts transplantation. Nowadays, these in vitro models have been increasing and widening their application areas, becoming important tools for research. This study is focus on the ability to design in vitro BASS which have been demonstrated to be appropriate to develop new products in the cosmetic and pharmacology industry. Allowing to go deeper into the skin disease research, and to analyze the effects provoked by envir
APA, Harvard, Vancouver, ISO, and other styles
21

Schwartz, James R., Randall G. Marsh, and Zoe Diana Draelos. "Zinc and Skin Health: Overview of Physiology and Pharmacology." Dermatologic Surgery 31 (March 21, 2006): 837–47. http://dx.doi.org/10.1111/j.1524-4725.2005.31729.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Brewer, Jonathan, Irina Iachina, M. A. Lomholt, Kim Nielsen, and Morten Ebbesen. "CARS microscopy for studies in skin physiology and pharmacology." BIO Web of Conferences 129 (2024): 14005. http://dx.doi.org/10.1051/bioconf/202412914005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Wu, Tianchi, and Yuhui Wang. "Mechanistic Study of Novel Whitening Agents: Insights from Molecular Dynamics, Molecular Docking, and Network Pharmacology." International Journal of Multidisciplinary Research and Growth Evaluation 6, no. 2 (2025): 982–87. https://doi.org/10.54660/.ijmrge.2025.6.2.982-987.

Full text
Abstract:
In this study, we systematically investigated the mechanism of action of a novel skin-whitening active compound (Compound identifier: SCHEMBL14462430, hereafter referred to as Compound X) using molecular docking, molecular dynamics simulations, and network pharmacology approaches. Molecular docking results demonstrated that Compound X exhibits significant binding interactions with tyrosinase, a key target in skin whitening, with a binding free energy of -7.8 kcal/mol, indicating favorable binding affinity. Molecular dynamics simulations further validated the stability of the Compound X-TYR com
APA, Harvard, Vancouver, ISO, and other styles
24

Alharbi, Albandary Falah, Wejdan Amein Abdullah, Jehan Khelaif Alanazi, et al. "The role of nursing, pharmacology, and diagnostics in pain management." International journal of health sciences 7, S1 (2023): 3288–98. http://dx.doi.org/10.53730/ijhs.v7ns1.14999.

Full text
Abstract:
Background: Severe burns affecting more than 20% of the body can lead to systemic dysfunction and immunological suppression, increasing the risk of developing skin cancer. This backdrop underscores the critical role of nursing in preventing complications associated with burn injuries, including cancer development. Aim of Work: This research aims to examine the role of nursing care in the prevention and management of post-burn skin cancer, highlighting the importance of a multidisciplinary approach to delivering optimal care for burn patients. Methods: An extensive literature review was conduct
APA, Harvard, Vancouver, ISO, and other styles
25

Ludington-Hoe, Susan M. "Skin-to-Skin Contact." MCN, The American Journal of Maternal/Child Nursing 40, no. 6 (2015): 359–66. http://dx.doi.org/10.1097/nmc.0000000000000178.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Billner-Garcia, Renee, Arlene Spilker, and Deepika Goyal. "Skin to Skin Contact." MCN, The American Journal of Maternal/Child Nursing 43, no. 3 (2018): 158–63. http://dx.doi.org/10.1097/nmc.0000000000000430.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Morse, Joanne K. "Thin Skin?" Clinical Research and Regulatory Affairs 19, no. 4 (2002): 413–16. http://dx.doi.org/10.1081/crp-120016437.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Guay, David RP. "Treatment of bacterial skin and skin structure infections." Expert Opinion on Pharmacotherapy 4, no. 8 (2003): 1259–75. http://dx.doi.org/10.1517/14656566.4.8.1259.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Nannini, Esteban C., Martin E. Stryjewski, and G. Ralph Corey. "Ceftaroline for complicated skin and skin-structure infections." Expert Opinion on Pharmacotherapy 11, no. 7 (2010): 1197–206. http://dx.doi.org/10.1517/14656561003777026.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Salinas, T., and M. Piquette-Miller. "Within Our Skin." Clinical Pharmacology & Therapeutics 102, no. 1 (2017): 8–12. http://dx.doi.org/10.1002/cpt.708.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Tymen, H., G. Rateau, K. Guillet, B. Ramounet-Le Gall, P. Gérasimo, and P. Fritsch. "Méthodes de mesure du transfert cutané des radionucléides au travers d'un épiderme intact ou lésé, application à la radiotoxicologie." Canadian Journal of Physiology and Pharmacology 80, no. 7 (2002): 733–41. http://dx.doi.org/10.1139/y02-096.

Full text
Abstract:
Although skin contamination by radionuclides is the most common cause of nuclear workers accidents, few studies dealing with the penetration of radioactive contamination through the skin are available. This work is a review of experimental methods that allow to assess transfer of radionuclides through the skin in occupational conditions, with or without skin trauma. The first section describes the different methods applied for skin transfer assessment of chemicals used in pharmacology. Major radionuclide contamination accidents can be associated with skin traumas. Thus, the second section desc
APA, Harvard, Vancouver, ISO, and other styles
32

Marks, Ronald, and Richard J. Motley. "Skin Cancer." Drugs 50, no. 1 (1995): 48–61. http://dx.doi.org/10.2165/00003495-199550010-00005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Bock, Jørgen, K. Th Kjølhede, and Erna Lund. "Skin Disinfection." Acta Pharmacologica et Toxicologica 9, no. 3 (2009): 201–14. http://dx.doi.org/10.1111/j.1600-0773.1953.tb02947.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Reichel, Mirja, Peter Heisig, Thomas Kohlmann, and Günter Kampf. "Alcohols for Skin Antisepsis at Clinically Relevant Skin Sites." Antimicrobial Agents and Chemotherapy 53, no. 11 (2009): 4778–82. http://dx.doi.org/10.1128/aac.00582-09.

Full text
Abstract:
ABSTRACT The antiseptic efficacy of ethanol, isopropanol, and n-propanol at 60%, 70%, and 89.5% (all vol/vol) was analyzed after 2, 3, or 4 min of application to the forehead, back, and abdomen of 180 volunteers by the use of a standardized swab sampling method. Results of recolonization by the aerobic skin flora of the upper arms and backs of 20 volunteers were compared 72 h after treatment with 0.5%, 1%, or 2% chlorhexidine digluconate (CHG) in 89.5% n-propanol. The most effective alcohol at all skin sites was n-propanol, with a mean log10 reduction of 1.82 after 2 min on the forehead. Effic
APA, Harvard, Vancouver, ISO, and other styles
35

Chan, Joseph C. "Combating Bacterial Resistance in Skin and Skin-Structure Infection." American Journal of Therapeutics 6, no. 1 (1999): 13–18. http://dx.doi.org/10.1097/00045391-199901000-00003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Buffoni, F., G. Banchelli, G. Ignesti, R. Pirisino, L. Raimondi, and Viale G. B. Morgagni. "Skin wound healing: Some biochemical parameters in guinea pig skin." Pharmacological Research 25 (May 1992): 332–33. http://dx.doi.org/10.1016/1043-6618(92)90432-b.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Perry, Margaret. "Fungal skin infections." Journal of Prescribing Practice 3, no. 8 (2021): 308–15. http://dx.doi.org/10.12968/jprp.2021.3.8.308.

Full text
Abstract:
Fungal infections of the skin continue to place a burden on healthcare and are a significant issue globally in terms of their cost and impact on resources. Some are more difficult to treat than others and there is a wide variation in duration of treatment, depending on the site and severity. Many fungal infections share similarities in appearance with other skin conditions, which can sometimes make diagnosis difficult. This article details some of the most common conditions and aims to give nurses and non-medical prescribers an overview of evidence-based treatment and management as well as to
APA, Harvard, Vancouver, ISO, and other styles
38

Bai, Yun, Yinjuan Wang, Huajun Zheng, Fei Tan, and Chao Yuan. "Correlation Between Facial Skin Microbiota and Skin Barriers in a Chinese Female Population with Sensitive Skin." Infection and Drug Resistance Volume 14 (January 2021): 219–26. http://dx.doi.org/10.2147/idr.s287844.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Prunieras, Michel. "On the Use of Cell Cultures in Skin Toxico-Pharmacology." International Journal of Dermatology 24, no. 1 (1985): 98–100. http://dx.doi.org/10.1111/j.1365-4362.1985.tb05387.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Prunieras, Michel. "On the Use of Cell Cultures in Skin Toxico-Pharmacology." International Journal of Dermatology 24, no. 2 (2007): 98–100. http://dx.doi.org/10.1111/j.1365-4362.1985.tb05731.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Shahbaz, Kiran. "Cephalosporins: pharmacology and chemistry." Pharmaceutical and Biological Evaluations 4, no. 6 (2017): 234. http://dx.doi.org/10.26510/2394-0859.pbe.2017.36.

Full text
Abstract:
Cephalosporins are the most important antibiotics having β-lactam ring and are obtained from a fungus Acremonium, also known as cephalosporium. The wide use of cephalosporins against bacteria in various severe infections such as respiratory tract infection (RTI), skin infection and urinary tract infection (UTI) has led the scientist dive into the detail of this antibacterial drug. The knowledge about structural activity relationship (SAR), spectrum of inhibition (SOI), chemical properties and pharmacology of cephalosporin has pivotal impact to device advanced therapeutic results. The treatment
APA, Harvard, Vancouver, ISO, and other styles
42

Nguyen, Michael, Manoj K. Poudel, Adam Michael Stewart, and Allan V. Kalueff. "Skin too thin? The developing utility of zebrafish skin (neuro)pharmacology for CNS drug discovery research." Brain Research Bulletin 98 (September 2013): 145–54. http://dx.doi.org/10.1016/j.brainresbull.2013.08.004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Soura, Efthymia, Vasiliki Chasapi, and Alexander J. Stratigos. "Pharmacologic treatment options for advanced epithelial skin cancer." Expert Opinion on Pharmacotherapy 16, no. 10 (2015): 1479–93. http://dx.doi.org/10.1517/14656566.2015.1052743.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Tack, Kenneth J., Thomas W. Littlejohn, Gail Mailloux, Michelle M. Wolf, and Constance H. Keyserling. "Cefdinir versus cephalexin for the treatment of skin and skin-structure infections." Clinical Therapeutics 20, no. 2 (1998): 244–56. http://dx.doi.org/10.1016/s0149-2918(98)80088-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Drusano, George L. "Early Endpoints for Acute Bacterial Skin and Skin Structure Infections." Antimicrobial Agents and Chemotherapy 56, no. 5 (2012): 2221–22. http://dx.doi.org/10.1128/aac.00157-12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Adianingsih, Oktavia Rahayu, Fifi Farida Fajrin, and Christopher Kuncoro Johan. "Exploring the mechanism of Glycyrrhiza glabra and Curcuma domestica against skin photoaging based on network pharmacology." Indonesian Journal of Biotechnology 29, no. 2 (2024): 98. http://dx.doi.org/10.22146/ijbiotech.93332.

Full text
Abstract:
Excessive exposure to UV radiation results in skin photoaging, which may be prevented or treated using natural plant compounds. Herbal cosmetics and medicines have grown in popularity due to the abundance of relatively safe compounds. This research aims to explore the network pharmacology of Glycyrrhiza glabra (GG) and Curcuma domestica (CD) against skin photoaging. Active compounds from GG‐CD were sourced from databases including TCSMP, KnapSack, TCMID, and published literature, while disease targets were collected from GeneCards and OMIM databases. The STRING database was utilized to constru
APA, Harvard, Vancouver, ISO, and other styles
47

Zhou, Ming, Guoyan Ren, Bin Zhang, Fuli Ma, Jinling Fan, and Zhijun Qiu. "Screening and identification of a novel antidiabetic peptide from collagen hydrolysates of Chinese giant salamander skin: network pharmacology, inhibition kinetics and protection of IR-HepG2 cells." Food & Function 13, no. 6 (2022): 3329–42. http://dx.doi.org/10.1039/d1fo03527d.

Full text
Abstract:
A new antidiabetic peptide was screened from the collagen hydrolysates of Andrias davidianus skin by the network pharmacology method, and its glucose-lowering activity was detected by α-glycosidase inhibition assay and cell assay.
APA, Harvard, Vancouver, ISO, and other styles
48

Park, Kyoung C., and Won S. Han. "Viral Skin Infections." Drugs 62, no. 3 (2002): 479–90. http://dx.doi.org/10.2165/00003495-200262030-00005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Hartmann, Anke, Eva-B. Br??cker, and J??rgen C. Becker. "Hypopigmentary Skin Disorders." Drugs 64, no. 1 (2004): 89–107. http://dx.doi.org/10.2165/00003495-200464010-00006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Ferrante, James A. "Infectious Skin Diseases." Primary Care: Clinics in Office Practice 17, no. 4 (1990): 867–81. http://dx.doi.org/10.1016/s0095-4543(21)00905-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!